AJP - Endo Information on EB 2010
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 291: E631-E638, 2006. First published May 2, 2006; doi:10.1152/ajpendo.00467.2005
0193-1849/06 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
291/3/E631    most recent
00467.2005v2
00467.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (3)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Spratt, D. I.
Right arrow Articles by Vary, C. P. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Spratt, D. I.
Right arrow Articles by Vary, C. P. H.

Increases in serum estrogen levels during major illness are caused by increased peripheral aromatization

Daniel I. Spratt,1 Jeremy R. Morton,2 Robert S. Kramer,2 Sara W. Mayo,2 Christopher Longcope,3 and Calvin P. H. Vary4

1Division of Reproductive Endocrinology, Department of Ob/Gyn; 2Department of Cardiac Services, Maine Medical Center, Portland, Maine; 3Detartment of Obstetrics and Gynecology, University of Massachusetts Medical School, Worcester, Massachusetts; and 4Center for Molecular Medicine, Maine Medical Center Research Institute, Scarborough, Maine

Submitted 25 September 2005 ; accepted in final form 13 April 2006

Although serum testosterone levels decrease acutely in critically ill patients, estrogen levels rise. We hypothesized that increased rates of aromatization of androgens to estrogens underlie the increase in serum estrogen levels. Eleven men and three women (age 42–69 yr) were prospectively studied before and again after elective coronary artery bypass graft surgery (CABG). Each patient received priming doses of [14C]androgen and [3H]estrogen that were immediately followed by peripheral infusions for 210 min. Eight men and three women received androstenedione (A4)/estrone (E1) and three men received testosterone (T)/estradiol (E2). Adipose tissue biopsies were obtained in another six men before and after CABG to evaluate levels of P450 aromatase mRNA. Serum T levels decreased postoperatively in all 17 men (P < 0.001), whereas E1 levels rose (P = 0.004), with a trend toward a rise in E2 (P = 0.23). Peripheral aromatization rates of androgens to estrogens rose markedly in all 14 patients (P < 0.0001). Estrogen clearance rates rose (P < 0.002). Mean serum A4 levels increased slightly postoperatively (P = 0.04), although no increase in A4 production rates (PRs) was observed. T PRs decreased in two of three men, whereas clearance rates increased in all three. Adipose tissue P450 aromatase mRNA content increased postoperatively (P < 0.001). We conclude that the primary cause of increased estrogen levels in acute illness is increased aromatase P450 gene expression, resulting in enhanced aromatization of androgens to estrogens, a previously undescribed endocrine response to acute illness. Both increased T clearance and decreased T production contribute to decreased serum T levels. Animal studies suggest that these opposing changes in circulating estrogen and androgen levels may be important to reduce morbidity and mortality in critical illness.

aromatase; cardiac surgery; estradiol; testosterone



Address for reprint requests and other correspondence: D. I. Spratt, Division of Reproductive Endocrinology, Dept. of Ob/Gyn, Maine Medical Center, Portland, ME 04102 (e-mail: spratd{at}mmc.org)




This article has been cited by other articles:


Home page
JAMAHome page
E. A. Jankowska, P. Rozentryt, B. Ponikowska, O. Hartmann, D. Kustrzycka-Kratochwil, K. Reczuch, J. Nowak, L. Borodulin-Nadzieja, L. Polonski, W. Banasiak, et al.
Circulating Estradiol and Mortality in Men With Systolic Chronic Heart Failure
JAMA, May 13, 2009; 301(18): 1892 - 1901.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
D. I. Spratt, R. S. Kramer, J. R. Morton, F. L. Lucas, K. Becker, and C. Longcope
Characterization of a prospective human model for study of the reproductive hormone responses to major illness
Am J Physiol Endocrinol Metab, July 1, 2008; 295(1): E63 - E69.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
J. L. Sperry and J. P. Minei
Gender dimorphism following injury: making the connection from bench to bedside
J. Leukoc. Biol., March 1, 2008; 83(3): 499 - 506.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
D. I. Spratt, M. Frohnauer, H. Cyr-Alves, R. S. Kramer, F. L. Lucas, J. R. Morton, D. F. Cox, K. Becker, and J. T. Devlin
Physiological effects of nonthyroidal illness syndrome in patients after cardiac surgery
Am J Physiol Endocrinol Metab, July 1, 2007; 293(1): E310 - E315.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2006 by the American Physiological Society.